WHO finds uneven respiratory virus activity in week 44 surveillance update
Global influenza test positivity was below 10% in the week ending 1 November. Sample rates are not population infection rates.
Article subject labels can be suggestions and are not editorial confirmation.
Global influenza test positivity was below 10% in the week ending 1 November. Sample rates are not population infection rates.
WHO says the countdown begins on 12 November. The outbreak has not yet been declared over; 23 December is conditional on no new cases.
The technical document separates testing and isolate counts by data stage. WHO’s announcement and catalogue page display different dates.
UNICEF reported more than 74 million doses procured and delivered by 22 October. That is a delivery count, distinct from completed vaccination courses or a 2030 target for children.
The existing International Pathogen Surveillance Network does not establish the claimed accreditation announcement.
National synchrotron facility unveils sub-angstrom macromolecular crystallography beamline enabling atomic-resolution analysis of membrane protein pathogens.
A clinical trial found partial protection and reported adverse events; it does not verify our claimed WHO decision.
Earlier WHO vaccine guidance does not establish the reported deal, prices or lifelong protection.
The updated guideline separates initial near-patient TB tests from targeted sequencing for drug resistance.
TDR reports an existing climate-informed system; the previously claimed WHO–WMO AI launch remains unsubstantiated.
Past emergency vaccine policies do not verify the reported decision or protection claimed for every age group.
WHO describes PCR testing and vaccination, but that does not verify the network and device claims in our report.